Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA

Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA

BackgroundA high proportion of patients with relapsing remitting multiple sclerosis convert to secondary progressive multiple sclerosis (SPMS) characterized by irreversibly progressing disability and cognitive decline. Siponimod (Mayzent), a selective sphingosine-1-phosphate...

Full description

Bibliographic Details
Main Authors: Ziemssen, Tjalf, Hoffmann, Olaf, Klotz, Luisa, Schreiber, Herbert, Weber, Martin S, Rauser, Benedict
Format: Article
Language:English
Published: JMIR Publications 2020-07-01
Series:JMIR Research Protocols
Online Access:http://www.researchprotocols.org/2020/7/e19598/

Internet

http://www.researchprotocols.org/2020/7/e19598/

Similar Items